modules | WHO PV workshop on active surveillance

Introduction

description and general safety considerations for implementation

Stakeholders in COVID-19 vaccine safety surveillance

Establishing surveillance systems in countries using COVID-19 vaccines

Responding to adverse events following COVID-19 immunization (AEFIs)

Establishing active surveillance systems for adverse events of special interest during COVID-19 vaccine introduction

Safety data management systems in countries using COVID-19 vaccines

Engaging with the pharmaceutical industry for COVID-19 vaccine safety surveillance

Regulatory reliance and work-sharing

 COVID-19 vaccine safety communication 